Medical News

RSS

Preclinical and Phase I data for TG-0054 presented by TaiGen Biotechnology

TaiGen Biotechnology Co., Ltd. announced today the presentation of Phase I and preclinical data for TG-0054, the Company's chemokine receptor CXCR4 antagonist and a novel, potent stem cell mobilizer, at the ASH Annual Meeting held in New Orleans, the US, from December 5 to 8, 2009.

7 Dec 2009

NHS teams up with international staff engagement specialists to improve patient care

The National Health Service (NHS), which manages 500 hospitals and over 1.5 million people in the UK, understands the value of an engaged staff: healthier and happier patients.

7 Dec 2009

APU offers tips and suggestions for safe holidays

The 2009 holiday season is officially underway – and while most of us look forward to the fun and excitement, some feel overwhelmed by the stress of office parties, family get-togethers, winter travel and grid-locked shopping mall parking lots.

7 Dec 2009

Football for Hope Centre opened in Khayelitsha

The first Football for Hope Centre in Khayelitsha in the outskirts of Cape Town opened its doors today (5 December 2009). FIFA President Joseph S. Blatter was joined by Western Cape Premier Helen Zille, 2010 FIFA World Cup Organising Committee South Africa (OC) CEO Danny Jordaan, South African Football Association President Kirsten Nematandani and Executive Mayor of the City of Cape Town Dan Plato at the celebration of the latest milestone of 20 Centres for 2010, the Official Campaign of the 2010 FIFA World Cup(TM).

7 Dec 2009

Kidneys from donors with renal masses to address the current organ shortage

Surgeons who successfully performed kidney transplants after removing small cancerous and benign masses from the donated organs, have published their results in the December issue of the UK-based urology journal BJUI.

7 Dec 2009

DirectView Holdings to facilitate the worldwide event for SIADTP's annual meeting

DirectView Holdings, Inc., a company focused on ownership and management of leading video and security technology companies, is pleased to announce that the Company has been chosen to facilitate a worldwide event for the Annual Meeting of the Iberoamerican Society for Prenatal Diagnosis and Therapy (Sociedad Iberoamericana de Diagnóstico y Tratamiento Prenatal -- SIADTP).

7 Dec 2009

Early antisocial behaviours and parental factors affect various health outcomes 40 years later

Men who have a history of delinquency in childhood are more likely to die or become disabled by the time they are 48, and not just from the obvious consequences of antisocial behaviour, new research indicates.

7 Dec 2009

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

Boehringer Ingelheim today announced very positive results from their landmark RE-COVER™ study – the most advanced trial programme assessing a novel oral anticoagulant in development for acute venous thromboemolism (VTE) treatment – presented at the American Society of Hematology Annual Meeting1 and published in the New England Journal of Medicine online.

7 Dec 2009

New oral drug is safe and effective to combat clotting disorder

A new study provides welcome news for patients with a common clotting disorder known as venous thromboembolism (VTE).

7 Dec 2009

Galapagos NV issues new shares

Galapagos NV (Euronext: GLPG) announced today a capital increase of EUR 902,564 and the issue of 225,641 new shares as a result of the exercise of warrants by Galapagos warrant holders, including CEO Onno van de Stolpe.

7 Dec 2009

UHC recognizes 10 AMC members for their achievements in Supply Chain Optimization Program

The University HealthSystem Consortium (UHC) recognized 10 academic medical center (AMC) members for their achievements in UHC's Supply Chain Optimization Program.

7 Dec 2009

Positive data from Gloucester Pharmaceuticals' ISTODAX study presented at the ASH meeting

Gloucester Pharmaceuticals announced today the presentation of positive data from an analysis of ISTODAX® (romidepsin) in a subset of patients from Gloucester’s registration study in cutaneous T-cell lymphoma (CTCL) at the 51st American Society of Hematology (ASH) Annual Meeting being held in New Orleans, LA.

7 Dec 2009

J&JPRD announces clinical results of new oral anticoagulant therapy for venous thromboembolism

Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).

7 Dec 2009

Computer search algorithms identify FDA-approved drugs that could be the basis for new medicines

A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1(avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies -- according to a presentation at the American Society for Cell Biology (ASCB) 49th Annual Meeting, Dec. 5-9, 2009 in San Diego.

7 Dec 2009

AHF hosts free rapid HIV testing in conjunction with Faithful Central Bible Church

In observation of World AIDS Day 2009, AIDS Healthcare Foundation (AHF), the largest global AIDS group which currently provides more than 15,000 free HIV and STD tests annually in California via its community-based testing programs, is hosting a day of free rapid HIV testing in conjunction with Faithful Central Bible Church this Sunday December 6th starting at 6:00am going until 4:00pm at the congregation’s church in Inglewood (321 Eucalyptus Street, Inglewood, 90301).

7 Dec 2009

CDC announces the start of National Influenza Vaccination Week

Today the Centers for Disease Control and Prevention (CDC) announced the start of National Influenza Vaccination Week. While the week was designed to highlight the importance of flu vaccinations, it also brings to light the importance of taking additional steps to keep you and your family healthy during the peak cold and flu season of December, January and beyond.

7 Dec 2009

Positive clinical data from Phase II study of elacytarabine in patients with AML reported

Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.

7 Dec 2009

SU2C awards $9.68 million to support high-risk cancer research

Stand Up To Cancer (SU2C) announced today that it is awarding $9.68 million to support high-risk/high-reward cancer research conducted by 13 young scientists.

7 Dec 2009

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. Sometimes, however, clots form on the inside of vessels without an obvious injury or do not dissolve naturally, a potentially life-threatening situation requiring treatment.

7 Dec 2009

Updated results from phase III EXTEND clinical trial of pixantrone released

Cell Therapeutics, Inc. ("CTI") announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology ("ASH") Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of pixantrone (the "PIX 301 EXTEND trial") in relapsed or refractory, aggressive non-Hodgkin's lymphoma ("NHL") patients who have failed 2 or more prior therapies.

7 Dec 2009

Medical News

Preclinical and Phase I data for TG-0054 presented by TaiGen Biotechnology

NHS teams up with international staff engagement specialists to improve patient care

APU offers tips and suggestions for safe holidays

Football for Hope Centre opened in Khayelitsha

Kidneys from donors with renal masses to address the current organ shortage

DirectView Holdings to facilitate the worldwide event for SIADTP's annual meeting

Early antisocial behaviours and parental factors affect various health outcomes 40 years later

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

New oral drug is safe and effective to combat clotting disorder

Galapagos NV issues new shares

UHC recognizes 10 AMC members for their achievements in Supply Chain Optimization Program

Positive data from Gloucester Pharmaceuticals' ISTODAX study presented at the ASH meeting

J&JPRD announces clinical results of new oral anticoagulant therapy for venous thromboembolism

Computer search algorithms identify FDA-approved drugs that could be the basis for new medicines

AHF hosts free rapid HIV testing in conjunction with Faithful Central Bible Church

CDC announces the start of National Influenza Vaccination Week

Positive clinical data from Phase II study of elacytarabine in patients with AML reported

SU2C awards $9.68 million to support high-risk cancer research

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Updated results from phase III EXTEND clinical trial of pixantrone released

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News